Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight
The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight
The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight
Submitted by
admin
on February 11, 2011 - 7:43am
Source:
Forbes
News Tags:
diabetes
insulin
Merck
GSK
Novo Nordisk
Eli Lilly
Headline:
The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight
Do Not Allow Advertisers to Use My Personal information
